Cognizant reports FY2025 revenue of USD 21.11 billion, up 10.5% in Products and Resources segment

Reuters
02/12
Cognizant reports FY2025 revenue of USD 21.11 billion, up 10.5% in Products and Resources segment

Cognizant reported revenues of USD 21.11 billion for the full year ended December 31, 2025, reflecting a 7.0% increase compared to the previous year. Revenue growth was primarily driven by the Financial Services and Health Sciences segments, each contributing significant gains, and the Products and Resources segment, which saw a 10.5% increase supported by the acquisition of Belcan. The Communications, Media and Technology segment experienced modest growth of 1.0%. The company attributed the overall revenue expansion to the ramp-up of several recently secured large deals, particularly in the Financial Services and Health Sciences sectors. In addition, the acquisition of Belcan contributed 260 basis points to overall revenue growth, with the most notable impact on the Products and Resources segment, especially in North America and to a lesser extent in the United Kingdom. Cognizant highlighted its focus on AI-driven solutions, emphasizing its role as an AI builder with expertise at the intersection of industry and technology. The company continues to support clients in modernizing technology, reimagining processes, and transforming experiences in a rapidly evolving business landscape.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cognizant Technology Solutions Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001058290-26-000008), on February 12, 2026, and is solely responsible for the information contained therein.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10